Evidence map›Paper›PMID 37635298›Full record

ArticleJournal of chemical information and modeling2023

SynRoute: A Retrosynthetic Planning Software.

Mario Latendresse, Jeremiah P Malerich, James Herson, Markus Krummenacker, Judy Szeto, Vi-Anh Vu, Nathan Collins, Peter B Madrid

Abstract read
In one paragraph

Article in Journal of chemical information and modeling, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Mario LatendresseSRI International, 333 Ravenswood Ave, Menlo Park, California 94025, United States.ORCID 0000-0002-6292-0158
Jeremiah P MalerichSRI International, 333 Ravenswood Ave, Menlo Park, California 94025, United States.
James HersonSRI International, 333 Ravenswood Ave, Menlo Park, California 94025, United States.
Markus KrummenackerSRI International, 333 Ravenswood Ave, Menlo Park, California 94025, United States.ORCID 0000-0002-2546-3007
Judy SzetoSRI International, 333 Ravenswood Ave, Menlo Park, California 94025, United States.
Vi-Anh VuSRI International, 333 Ravenswood Ave, Menlo Park, California 94025, United States.
Nathan CollinsSRI International, 333 Ravenswood Ave, Menlo Park, California 94025, United States.
Peter B MadridSRI International, 333 Ravenswood Ave, Menlo Park, California 94025, United States.ORCID 0000-0002-4895-5610

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Computer-assisted synthetic planning has seen major advancements that stem from the availability of large reaction databases and artificial intelligence methodologies. SynRoute is a new retrosynthetic planning software tool that uses a relatively small number of general reaction templates, currently 263, along with a literature-based reaction database to find short, practical synthetic routes for target compounds. For each reaction template, a machine learning classifier is trained using data from the Pistachio reaction database to predict whether new computer-generated reactions based on the template are likely to work experimentally in the laboratory. This reaction generation methodology is used together with a vectorized Dijkstra-like search of top-scoring routes organized by synthetic strategies for easy browsing by a synthetic chemist. SynRoute was able to find routes for an average of 83% of compounds based on selection of random subsets of drug-like compounds from the ChEMBL database. Laboratory evaluation of 12 routes produced by SynRoute, to synthesize compounds not from the previous random subsets, demonstrated the ability to produce feasible overall synthetic strategies for all compounds evaluated.

Indexed as

Artificial IntelligenceSoftwareDatabases, FactualMachine Learning

Identifiers

PMID37635298
PMCPMC10498441

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.